转录组学,蛋白质组学和功能丧失查的整合显示,WEE1是与达沙替尼结合用于对抗proneural glioblastoma 的标

Obada T Alhalabi1, Mona Göttmann2, Maxwell P Gold3

  • 1Brain Tumor Translational Targets, DKFZ Junior Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany.

Cancer letters
|September 27, 2024
PubMed
概括

这项研究确定WEE1是治疗质母细胞瘤的有希望的药物标. 将达沙替尼与WEE1抑制剂MK-1775结合起来,通过诱导DNA损伤,协同杀死proneural glioblastoma干细胞.